Longboard Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Longboard Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $66.34 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2024-11-07
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $66.34M.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $48.91M.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $32.57M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $2.83M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value as first filed |
|---|---|---|
| 2024-09-30 | $66.34M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $48.91M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $32.57M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $2.83M 10-K · filed 2024-03-12 | |
| 2023-09-30 | $2.13M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $4.09M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $427.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $48.00K 10-K · filed 2023-03-02 | |
| 2022-09-30 | $234.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.13M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $814.00K 10-K · filed 2022-03-03 | |
| 2021-09-30 | $2.10M 10-Q · filed 2021-11-04 | |
| 2021-03-31 | $4.70M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $200.00K 10-Q · filed 2021-11-04 | $2.20M 10-Q · filed 2021-08-09 |